Literature DB >> 22012705

Synthesis of chondramide A analogues with modified β-tyrosine and their biological evaluation.

Alexander Zhdanko1, Anke Schmauder, Christopher I Ma, L David Sibley, David Sept, Florenz Sasse, Martin E Maier.   

Abstract

Starting from cinnamates 9, obtained by Wittig reaction or Heck coupling, the diols 17 were prepared by asymmetric dihydroxylation. This was followed by a regioselective substitution of the 3-OH group with hydrazoic acid under Mitsunobu conditions. Methylation of the 2-OH group and reduction of the azide group led to the β-tyrosine derivatives 8. Condensation with the dipeptide acid 6 furnished the tripeptide part of the chondramides. The derived acids 21 were combined with the hydroxy ester 7 to the esters 22. Cleavage of the tert-butyl groups and intramolecular lactam formation gave rise to the chondramide A analogues 2 b-k. Growth inhibition assays showed most of the analogues to be biologically active. Some of them even reach the activity of jasplakinolide. It can be concluded that the 4-position of the aryl ring in the β-tyrosine of chondramide A tolerates structural modifications quite well.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22012705      PMCID: PMC3228261          DOI: 10.1002/chem.201101978

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  32 in total

1.  New jaspamide derivatives from the marine sponge Jaspis splendans collected in Vanuatu.

Authors:  A Zampella; C Giannini; C Debitus; C Roussakis; M V D'Auria
Journal:  J Nat Prod       Date:  1999-02       Impact factor: 4.050

Review 2.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

Review 3.  Disruption of protein-protein interactions: towards new targets for chemotherapy.

Authors:  Arianna Loregian; Giorgio Palù
Journal:  J Cell Physiol       Date:  2005-09       Impact factor: 6.384

4.  Synthesis, solution structure, and bioactivity of six new simplified analogues of the natural cyclodepsipeptide jaspamide.

Authors:  Stefania Terracciano; Ines Bruno; Giuseppe Bifulco; Elvira Avallone; Charles D Smith; Luigi Gomez-Paloma; Raffaele Riccio
Journal:  Bioorg Med Chem       Date:  2005-09-01       Impact factor: 3.641

5.  Mitsunobu and related reactions: advances and applications.

Authors:  K C Kumara Swamy; N N Bhuvan Kumar; E Balaraman; K V P Pavan Kumar
Journal:  Chem Rev       Date:  2009-06       Impact factor: 60.622

6.  Solid-phase based synthesis of jasplakinolide analogs by intramolecular azide-alkyne cycloadditions.

Authors:  Tai-Shan Hu; René Tannert; Hans-Dieter Arndt; Herbert Waldmann
Journal:  Chem Commun (Camb)       Date:  2007-08-14       Impact factor: 6.222

7.  (-)-Doliculide, a new macrocyclic depsipeptide enhancer of actin assembly.

Authors:  Ruoli Bai; David G Covell; Chunfeng Liu; Arun K Ghosh; Ernest Hamel
Journal:  J Biol Chem       Date:  2002-06-20       Impact factor: 5.157

8.  Chondramides A approximately D, new antifungal and cytostatic depsipeptides from Chondromyces crocatus (myxobacteria). Production, physico-chemical and biological properties.

Authors:  B Kunze; R Jansen; F Sasse; G Höfle; H Reichenbach
Journal:  J Antibiot (Tokyo)       Date:  1995-11       Impact factor: 2.649

Review 9.  Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer.

Authors:  Sharmila Patel; Mark R Player
Journal:  Expert Opin Investig Drugs       Date:  2008-12       Impact factor: 6.206

10.  Synthesis and biological evaluation of cruentaren A analogues.

Authors:  Viktor V Vintonyak; Marcellino Calà; Frank Lay; Brigitte Kunze; Florenz Sasse; Martin E Maier
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

View more
  1 in total

1.  Synthetic chondramide A analogues stabilize filamentous actin and block invasion by Toxoplasma gondii.

Authors:  Christopher I Ma; Karthikeyan Diraviyam; Martin E Maier; David Sept; L David Sibley
Journal:  J Nat Prod       Date:  2013-09-10       Impact factor: 4.050

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.